oncotomskСибирский онкологический журналSiberian journal of oncology1814-48612312-3168Tomsk National Research Medical Сепtеr of the Russian Academy of Sciencesoncotomsk-177Research ArticleОБЗОРЫREVIEWSЭПИДЕМИОЛОГИЯ ЗЛОКАЧЕСТВЕННЫХ НОВООБРАЗОВАНИЙ В МИРЕWORLDWIDE CANCER EPIDEMIOLOGYОдинцоваИ. Н.OdintsovaI. N.

Одинцова Ирина Николаевна, доктор медицинских наук, заведующая лабораторией эпидемиологии.

E-mail: OdintsovaIN@oncology.tomsk.ru. SPIN-код: 4631-9100

Odintsova Irina Nikolaevna, MD, DSc, Head of Epidemiology Laboratory. 

E-mail: OdintsovaIN@oncology.tomsk.ru. SPIN-code: 4631-9100

OdintsovaIN@oncology.tomsk.ruПисареваЛ. Ф.PisarevaL. F.

Писарева Любовь Филипповна, доктор медицинских наук, профессор, главный научный сотрудник лаборатории эпидемиологии.

E-mail: PisarevaLF@oncology.tomsk.ru. SPIN-код: 3529-0202

Pisareva Ljubov Filippovna, MD, DSc, Professor, Principle Investigator, Epidemiology Labboratory. 

E-mail: PisarevaLF@oncology.tomsk.ru. SPIN-код: 3529-0202

PisarevaLF@oncology.tomsk.ruХряпенковА. В.KhryapenkovA. V.

Хряпенков Александр Владимирович, главный врач

Khryapenkov Alexandr Vladimirovich, Head Physicion /span>

Томский НИИ онкологииРоссияTomsk Cancer Research InstituteRussian FederationЧойская центральная районная больница, Республика Алтай, с. ЧояРоссияChoya Central District Hospital, the Altai Republic, ChoyaRussian Federation2015190220161595101Copyright © Одинцова И.Н., Писарева Л.Ф., Хряпенков А.В., 20162016Одинцова И.Н., Писарева Л.Ф., Хряпенков А.В.Odintsova I.N., Pisareva L.F., Khryapenkov A.V.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.siboncoj.ru/jour/article/view/177

В обзоре представлены данные о заболеваемости и смертности от злокачественных новообразований и о факторах риска их развития в различных странах мира.

The review presents the worldwide data on the cancer incidence and mortality and risk factors for cancer.

злокачественные новообразованиязаболеваемостьсмертностьReferencesAllemani C., Weir H.K., Carreira H., Harewood R., Spika D., Wang X.S., Bannon F., Ahn J.V., Johnson C.J., Bonaventure A., MarcosGragera R., Stiller C., Azevedo e Silva G., Chen W.Q., Ogunbiyi O.J., Rachet B., Soeberg M.J., You H., Matsuda T., Bielska-Lasota M., Storm H., Tucker T.C., Coleman M.P.; CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25, 676, 887 patients from 279 population-based registries in 67 countries (CONCORD-2) // The Lancet. 2015. Vol. 385 (9972). P. 977–1010. doi: 10.1016/S0140-6736(14)62038-9.Allemani C., Weir H.K., Carreira H., Harewood R., Spika D., Wang X.S., Bannon F., Ahn J.V., Johnson C.J., Bonaventure A., Marcos-Gragera R., Stiller C., Azevedo e Silva G., Chen W.Q., Ogunbiyi O.J., Rachet B., Soeberg M.J., You H., Matsuda T., Bielska-Lasota M., Storm H., Tucker T.C., Coleman M.P.; CONCORD Working Group. Global surveillance of cancer survival 1995–2009: analysis of individual data for 25, 676, 887 patients from 279 population-based registries in 67 countries (CONCORD-2) // The Lancet. 2015. Vol. 385 (9972). P. 977–1010. doi: 10.1016/S01406736(14)62038-9.Bosetti C., Bertuccio P., Levi F., Lucchini F., Negri E., La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis // Ann. Oncol. 2008. Vol. 19 (4). P. 631–640. doi: 10.1093/annonc/mdm597.Bosetti C., Bertuccio P., Levi F., Lucchini F., Negri E., La Vecchia C. Cancer mortality in the European Union, 1970–2003, with a joinpoint analysis // Ann. Oncol. 2008. Vol. 19 (4). P. 631–640. doi: 10.1093/annonc/mdm597.Bray F., Jemal A., Grey N., Ferlay J., Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study // Lancet Oncol. 2012. Vol. 13 (8). Р. 790–801. doi: 10.1016/S1470-2045(12)70211-5.Bray F., Jemal A., Grey N., Ferlay J., Forman D. Global cancer transitions according to the Human Development Index (2008–2030): a population-based study // Lancet Oncol. 2012. Vol. 13 (8). Р. 790–801. doi: 10.1016/S1470-2045(12)70211-5.Butel J.S., Fan H. The diversity of human cancer viruses // Curr. Opin. Virol. 2012. Vol. 2 (4). P. 449–452. doi: 10.1016/j.coviro.2012.07.002.Butel J.S., Fan H. The diversity of human cancer viruses // Curr. Opin. Virol. 2012. Vol. 2 (4). P. 449–452. doi: 10.1016/j.coviro.2012.07.002.Canadian Cancer Statistics 2014. URL: http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian% 20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf. (28.04.2015).Canadian Cancer Statistics 2014. URL: http://www.cancer.ca/~/media/cancer.ca/CW/cancer%20information/cancer%20101/Canadian%20cancer%20statistics/Canadian-Cancer-Statistics-2014-EN.pdf. (28.04.2015).Cancer Incidence in Five Continents / Ed. by D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Piñeros, E. SteliarovaFoucher, R. Swaminathan, J. Ferlay Lyon: IARC, 2013. Vol. X. URL: http://www.iarc.fr/en/publications/pdfs-online/epi/sp164/CI5volX_Full.pdf. (28.04.2015).Cancer Incidence in Five Continents // Ed. by D. Forman, F. Bray, D.H. Brewster, C. Gombe Mbalawa, B. Kohler, M. Piñeros, E. SteliarovaFoucher, R. Swaminathan, J. Ferlay. Lyon: IARC, 2013. Vol. X. URL: http://www.iarc.fr/en/publications/pdfs-online/epi/sp164/CI5volX_Full.pdf. (28.04.2015).Cancer in Wales: 2001–2013. URL: http://www.wcisu.wales.nhs.uk/sitesplus/documents/1111/WCISU%20Official%20Stats%20Report%20Final%20English.pdf. (28.04.2005).Cancer in Wales: 2001–2013. URL: http://www.wcisu.wales.nhs.uk/sitesplus/documents/1111/WCISU%20Official%20Stats%20Report%20Final%20English.pdf. (28.04.2005).De Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis // Lancet Oncol. 2012. Vol. 13 (6). Р. 607–615. doi: 10.1016/S1470-2045(12)70137-7.De Martel C., Ferlay J., Franceschi S., Vignat J., Bray F., Forman D., Plummer M. Global burden of cancers attributable to infections in 2008: a review and synthetic analysis // Lancet Oncol. 2012. Vol. 13 (6). Р. 607–615. doi: 10.1016/S1470-2045(12)70137-7.Elkin E.B., Bach P.B. Cancer’s next frontier: addressing high and increasing costs // JAMA. 2010. Vol. 303 (11). Р. 1086–1087. doi: 10.1001/ jama.2010.283.Elkin E.B., Bach P.B. Cancer’s next frontier: addressing high and increasing costs // JAMA. 2010. Vol. 303 (11). Р. 1086–1087. doi: 10.1001/jama.2010.283.El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma // Gastroenterology. 2012. Vol. 142 (6). P. 1264–1273. doi: 10.1053/j.gastro.2011.12.061.El-Serag H.B. Epidemiology of viral hepatitis and hepatocellular carcinoma // Gastroenterology. 2012. Vol. 142 (6). P. 1264–1273. doi: 10.1053/j.gastro.2011.12.061.Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 // Eur. J. Cancer. 2013. Vol. 49 (6). Р. 1374–1403. doi: 10.1016/j.ejca.2012.12.027.Ferlay J., Steliarova-Foucher E., Lortet-Tieulent J., Rosso S., Coebergh J.W., Comber H., Forman D., Bray F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 // Eur. J. Cancer. 2013. Vol. 49 (6). Р. 1374–1403. doi: 10.1016/j.ejca.2012.12.027.GLOBOCAN 2012. URL: http://globocan.iarc.fr. (08.05.2015).GLOBOCAN 2012. URL: http://globocan.iarc.fr. (08.05.2015).Global Cancer Facts & Figures. 3rd Edition is a publication of the American Cancer Society, Atlanta, Georgia. URL: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-044738.pdf. (08.05.2015).Global Cancer Facts & Figures. 3rd Edition is a publication of the American Cancer Society, Atlanta, Georgia. URL: http://www.cancer.org/acs/groups/content/@research/documents/document/acspc-044738.pdf. (08.05.2015).Hanly P., Soerjomataram I., Sharp L. Measuring the societal burden of cancer: The cost of lost productivity due to premature cancerrelated mortality in Europe // Int. J. Cancer. 2015. Vol. 136 (4). Р. 136–145. doi: 10.1002/ijc.29105.Hanly P., Soerjomataram I., Sharp L. Measuring the societal burden of cancer: The cost of lost productivity due to premature cancerrelated mortality in Europe // Int. J. Cancer. 2015. Vol. 136 (4). Р. 136–145. doi: 10.1002/ijc.29105.Jemal A., Center M.M., De Santis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends // Cancer Epidemiol. Biomarkers Prev. 2010. Vol. 19 (8). Р. 1893–1907. doi: 10.1158/10559965.EPI-10-0437.Jemal A., Center M.M., De Santis C., Ward E.M. Global patterns of cancer incidence and mortality rates and trends // Cancer Epidemiol. Biomarkers Prev. 2010. Vol. 19 (8). Р. 1893–1907. doi: 10.1158/10559965.EPI-10-0437.Katanoda K., Matsuda T., Matsuda A., Shibata A., Nishino Y., Fujita M., Soda M., Ioka A., Sobue T., Nishimoto H. An updated report of the trends in cancer incidence and mortality in Japan // Jpn. J. Clin. Oncol. 2013. Vol. 43 (5). Р. 492–507. doi: 10.1093/jjco/hyt038.Katanoda K., Matsuda T., Matsuda A., Shibata A., Nishino Y., Fujita M., Soda M., Ioka A., Sobue T., Nishimoto H. An updated report of the trends in cancer incidence and mortality in Japan // Jpn. J. Clin. Oncol. 2013. Vol. 43 (5). Р. 492–507. doi: 10.1093/jjco/hyt038.Kutok J.L., Wang F. Spectrum of Epstein-Barr virus-associated disease // Annu Rev. Pathol. 2006. Vol. 1. P. 375–404.Kutok J.L., Wang F. Spectrum of Epstein-Barr virus-associated disease // Annu Rev. Pathol. 2006. Vol. 1. P. 375–404.Malvezzi M., Bertuccio P., Rosso T., Rota M., Levi F., La Vecchia C., Negri E. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? // Ann Oncol. 2015. Vol. 26 (4). P. 779–786. doi: 10.1093/annonc/mdv001.Malvezzi M., Bertuccio P., Rosso T., Rota M., Levi F., La Vecchia C., Negri E. European cancer mortality predictions for the year 2015: does lung cancer have the highest death rate in EU women? // Ann Oncol. 2015. Vol. 26 (4). P. 779–786. doi: 10.1093/annonc/mdv001.National Healthcare Quality Report, 2013. URL: http://www.ahrq.gov/sites/default/files/publications/files/2013nhqr.pdf. (08.05.2015).National Healthcare Quality Report, 2013. URL: http://www.ahrq.gov/sites/default/files/publications/files/2013nhqr.pdf. (08.05.2015).Tarawneh M., Nimri O., Arkoob K., AL Zaghal M. Cancer Incidence in Jordan 2009. URL: http://www.moh.gov.jo/MOH/arabic/publications.php. (28.04.2015).Tarawneh M., Nimri O., Arkoob K., AL Zaghal M. Cancer Incidence in Jordan 2009. URL: http://www.moh.gov.jo/MOH/arabic/publications. php. (28.04.2015).The World Bank (2015). Data: Population ages 65 and above (% of total). URL http://data.worldbank.org/indicator. (08.09.2015).The World Bank (2015). Data: Population ages 65 and above (% of total). URL http://data.worldbank.org/indicator. (08.09.2015).Viruses and Human Cancer. From Basic Science to Clinical Prevention // Ed. by M.H. Chang, K.-T. Jeang. Springer, 2014. 290 p. doi: 10.1007/978-3-642-38965-8.Viruses and Human Cancer. From Basic Science to Clinical Prevention // Ed. by M.H. Chang, K-T. Jeang. Springer, 2014. 290 p. doi: 10.1007/978-3-642-38965-8.World Health Organization Global Health Observatory Data Repository, Mortality and Global Health Estimates 2012. URL: apps.who. int/gho/data. (24. 08. 2014).World Health Organization Global Health Observatory Data Repository, Mortality and Global Health Estimates 2012. URL: apps.who.int/gho/data. (24. 08. 2014).World Health Statistics 2014. URL: http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.pdf. (22.04.2015).World Health Statistics 2014. URL: http://apps.who.int/iris/bitstream/10665/112738/1/9789240692671_eng.pdf. (22.04.2015).

The authors declare that there are no conflicts of interest present.